Fructose consumption and its health implications; fructose malabsorption and nonalcoholic fatty liver disease;Consumo de fructosa y sus implicaciones para la salud; malabsorción de fructosa e hígado graso no alcohólico

Nutricion Hospitalaria

Volumn 29, Issue 3, 2014, Pages 491-499

  Riveros, María Jesús ^a   Parada, Alejandra ^a   Pettinelli, Paulina ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Fructose intake; Fructose malabsorption; Nonalcoholic fatty liver and fructose

Indexed keywords

FRUCTOSE; SWEETENING AGENT;

FEEDING BEHAVIOR; HEALTH STATUS; HUMAN; MALABSORPTION; META ANALYSIS; METABOLISM; NONALCOHOLIC FATTY LIVER;

FOOD HABITS; FRUCTOSE; HEALTH STATUS; HUMANS; MALABSORPTION SYNDROMES; NON-ALCOHOLIC FATTY LIVER DISEASE; SWEETENING AGENTS;

EID: 84896882690     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/NH.2014.29.3.7178     Document Type: Review

References (78)

1. Douard V, Ferraris RP. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab 2008; 295: 227-37.
2. Bray GA. How bad is fructose? Am J Clin Nutr 2007; 86: 895-6.
3. Gross LS, Li L, Ford ES, Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004; 79: 774-9.
4. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 2002; 76: 5-56.
5. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 2010; 7: 251-64.
6. Malik VS, Hu FB. Sweeteners and Risk of Obesity and Type 2 Diabetes: The Role of Sugar-Sweetened Beverages. Curr Diab Rep 2012 [Epub ahead of print].
7. Ferder L, Ferder MD, Inserra F. The role of high-fructose corn syrup in metabolic syndrome and hypertension. Curr Hypertens Rep 2010; 12: 105-12.
8. Putnam J, Allshouse J. Food consumption, prices and expenditures, 1970-1997. Economy Research Service USDA. Disponible en: www.ers.usda.gov [Consultado el 5 de marzo 2013].
9. Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med 2008; 10: 160.
10. Bleich SN, Wang YC, Wang Y, Gortmaker SL. Increasing consumption of sugar-sweetened beverages among US adults: 1988-1994 to 1999-2004. Am J Clin Nutr 2009; 89: 372-81.
11. Duffey KJ, Huybrechts I, Mouratidou T, Libuda L, Kersting M, De Vriendt T et al. Beverage consumption among European adolescents in the HELENA study. Eur J Clin Nutr 2012; 66: 244-52.
12. Barquera S, Campirano F, Bonvecchio A, Hernández-Barrera L, Rivera JA, Popkin BM. Caloric beverage consumption patterns in Mexican children. Nutr J 2010; 9: 47.
13. Asociación Nacional de Bebidas Refrescantes (ANBER). Resultados finales, Estadística total ventas año 2009-2011. Disponible en www.anber.cl [Consultado el 5 de marzo 2013].
14. Ministerio de Salud (MINSAL). Encuesta Nacional de Consumo Alimentario. 2010. Disponible en: www.minsal.cl [Consultado el 5 de mayo 2013].
15. Tappy L, Lê KA. Metabolic Effects of Fructose and the Worldwide Increase in Obesity. Physiol Rev 2010; 90: 23-46.
16. Lustig RH. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc 2010; 110: 1307-21.
17. Cui XL, Ananian C, Perez E, Strenger A, Beuve AV, Ferraris RP. Cyclic AMP stimulates fructose transport in neonatal rat small intestine. J Nutr 2004; 134: 1697-703.
18. Manolescu AR, Augustin R, Moley K, Cheeseman C. A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity. Mol Membr Biol 2007; 24: 455-63.
19. Hoekstra JH, van den Aker JH. Facilitating effect of amino acids on fructose and sorbitol absorption in children. J Pediatr Gastroenterol Nutr 1996; 23: 118-24.
20. Fernández-Bañares F, Esteve M, Viver JM. Fructose-sorbitol malabsorption. Curr Gastroenterol Rep 2009; 11: 368-74.
21. Zakim D. Influence of fructose of hepatic synthesis of lipids. Prog Biochem Pharmacol 1973; 8: 161-88.
22. Hudgins LC. Effect of high-carbohydrate feeding on triglyceride and saturated fatty acid synthesis. Proc Soc Exp Biol Med 2000; 225: 178-83.
23. Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem 2012; 23: 203-8.
24. Rumessen JJ, Gudmand-Høyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 1986; 27: 1161-8.
25. Szilagyi A, Malolepszy P, Yesovitch S, Vinokuroff C, Nathwani U, Cohen A, Xue X. Fructose malabsorption may be gender dependent and fails to show compensation by colonic adaptation. Dig Dis Sci 2007; 52: 2999-3004.
26. Gibson PR, Newnham E, Barrett JS, Shepherd SJ, Muir JG. Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther 2007; 25: 349-63.
27. Yoshida M, McKeown NM, Rogers G, Meigs JB, Saltzman E, D'Agostino R et al. Surrogate markers of insulin resistance are associated with consumption of sugar sweetened drinks and fruit juice in middle and older aged adults. J Nutr 2007; 137: 2121-7.
28. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1961-71.
29. Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 2012; 56: 952-60.
30. Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr 2009; 89: 1037-42.
31. Bouteldja N, Timson DJ. The biochemical basis of hereditary fructose intolerance. J Inherit Metab Dis 2010; 33: 105-12.
32. Jones HF, Butler RN, Brooks DA. Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol 2011; 300: 202-6.
33. Frieling T, Kuhlbusch-Zicklam R, Kalde S, Heise J, Hülsdonk A, Kreysel C. Fructose Malabsorption: how much fructose can a healthy subject tolerate? Digestion 2011; 84: 269-72.
34. Gijsbers CF, Kneepkens CM, Büller HA. Lactose and fructose malabsorption in children with recurrent abdominal pain: results of double-blinded testing. Acta Pediatr 2012; 101: 411-5.
35. Simrén M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006; 55: 297-303.
36. Rumessen JJ, Gudmand-Høyer E. Malabsorption of fructose-sorbitol mixtures. Interactions causing abdominal distress. Scand J Gastroenterol 1987; 22: 431-6.
37. Densupsoontorn N, Jirapinyo P, Thamonsiri N, Wongarn R. Fructose malabsorption in Thai adult. Asia Pac J Clin Nutr 2007; 16: 209-12.
38. Rao SS, Attaluri A, Anderson L, Stumbo P. Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol 2007; 5: 959-63.
39. Ravich WJ, Bayless TM, Thomas M. Fructose: incomplete intestinal absorption in humans. Gastroenterology 1983; 84: 26-9.
40. Barrett JS, Irving PM, Shepherd SJ, Muir JG. Gibson PR. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther 2009; 30: 165-74.
41. Kellett GL, Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 2005; 54: 3056-62.
42. Drozdowski LA, Thomson AB. Intestinal sugar transport. World J Gastroenterol 2006; 12: 1657-70.
43. Fernández-Bañares F, Rosinach M, Esteve M, Forné M, Espinós JC, Maria Viver J. Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment. Clin Nutr 2006; 25: 824-31.
44. Fernández-Bañares F, Esteve-Pardo M, de Leon R, Humbert P, Cabré E, Llovet JM et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol 1993; 88: 2044-50.
45. Videla LA, Rodrigo R, Araya J, Poniachik J. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol Med 2006; 12: 555-8.
46. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-93.
47. Adams LA, Lindor KD. Nonalcoholic fatty liver disease. Ann Epidemiol 2007; 17: 863-9.
48. Roberts EA. Non-alcoholic steatohepatitis in children. Clin Liver Dis 2007; 11: 155-72.
49. Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006; 82: 315-22.
50. Marchesini G, Pagotto U, Bugianesi E, De Iasio R, Manini R, Vanni E et al. Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. J Clin Endocrinol Metab 2003; 88: 5674-9.
51. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-10.
52. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-5.
53. Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M. Treating nonalcoholic fatty liver disease. Liver Int 2007; 27: 1157-65.
54. Anderson GH. Much ado about high-fructose corn syrup in beverages: the meat of the matter. Am J Clin Nutr 2007; 86: 1577-8.
55. Musso G, Gambino R, Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 2010; 11: 430-45.
56. Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem 2012; 23: 203-8.
57. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119: 1322-34.
58. Kavanagh K, Wylie AT, Tucker KL, Hamp TJ, Gharaibeh RZ, Fodor AA et al. Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates. Am J Clin Nutr 2013; 98: 349-57.
59. Kawasaki T TS, Kiso S, Doi Y, Yoshida Y, Kamada Y, Saeki A et al. Effects of growth factors on the growth and differentiation of mouse fetal liver epithelial cells in primary cultures. J Gastroenterol Hepatol 2005; 20: 857-64.
60. Sánchez-Lozada LG, Mu W, Roncal C, Sautin YY, Abdelmalek M, Reungjui S, et al. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. Eur J Nutr 2010; 49: 1-9.
61. Nagai Y, Nishio Y, Nakamura T, Maegawa H, Kikkawa R, Kashiwagi A. Amelioration of high fructose-induced metabolic derangements by activation of PPAR. Am J Physiol Endocrinol Metab 2002; 282: E1180-90.
62. Roglans N, Vilà L, Farré M, Alegret M, Sánchez RM, Vázquez-Carrera M et al. Impairment of Hepatic Stat-3 Activation and Reduction of PPAR Activity in Fructose-Fed Rats. Hepathology 2007; 45: 778-88.
63. Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G et al. Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. Hypertension 2005; 45: 1012-8.
64. Armutcu F, Coskun O, Gürel A, Kanter M, Can M, Ucar F et al. Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin Biochem 2005; 38: 540-7.
65. Kawasaki T, Igarashi K, Koeda T, Sugimoto K, Nakagawa K, Hayashi S, et al. Rats Fed Fructose-Enriched Diets Have Characteristics of Nonalcoholic Hepatic Steatosis. J Nutr 2009; 139: 2067-71.
66. Castro GS, Cardoso JF, Vannucchi H, Zucoloto S, Jordão AA. Fructose and NAFLD: metabolic implications and models of induction in rats. Acta Cir Bras 2011; 26 (Suppl. 2): 45-50.
67. Tsai J, Zhang R, Qiu W, Su Q, Naples M, Adeli K. Inflammatory NF-B activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production. Am J Physiol Gastrointest Liver Physiol 2009; 296: G1287-98.
68. Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 2009; 50: 772-80.
69. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904.
70. Pollock NK, Bundy V, Kanto W, Davis CL, Bernard PJ, Zhu H et al. Greater Fructose Consumption Is Associated with Cardiometabolic Risk Markers and Visceral Adiposity in Adolescents. J Nutr 2012; 142: 251-7.
71. Stanhope KL, Bremer AA, Medici V, Nakajima K, Ito Y, Nakano T et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab 2011; 96: E1596-605.
72. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008; 48: 993-9.
73. Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 2009; 139: 1228S-1235S.
74. Gouyon F, Caillaud L, Carriere V, Klein C, Dalet V, Citadelle D et al. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol 2003; 1; 552: 823-32.
75. Vos MB, Lavine JE. Dietary fructose in nonalcoholic fatty liver disease. Hepatology 2013; 57: 2525-31.
76. Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism and the Council on Epidemiology and Prevention. Circulation 2009; 120: 1011-20.
77. United State Departament of Agriculture (USDA). Dietary Guidelines 2010. Disponible en: www.cnpp.usda.gov
78. Ministerio de Salud (MINSAL). Guías alimentarias 2013. Disponible en: www.minsal.cl [Consultado el 21 de noviembre 2013].